What Stage IIIB Means
T4aN1–2M0 or T3N2M0. Tumor invades adjacent structures or extensive nodal disease.
Treatment Approach for Stage IIIB
Neoadjuvant CRT with 50.4–60 Gy. Surgery if resectable post-treatment. Palliative CRT if unresectable.
Survival Rates and Prognosis
The 5-year survival rate for esophageal cancer at Stage IIIB is approximately 5-year survival: 10–20%. Survival rates are statistical averages drawn from large patient populations and may not reflect your individual outcome. Factors that influence your specific prognosis include your age, overall health, tumour biology, and how well the cancer responds to treatment.
Important: These numbers are drawn from historical data. Newer treatments available today may improve outcomes beyond what published statistics show. Discuss your individual prognosis with your oncologist.
How Other Stages Compare
| Stage | 5-Year Survival | Treatment |
|---|---|---|
| Stage I | 5-year survival: 40–50% | Endoscopic resection if T1a, N0. Surgery (esophagectomy) if T1b–2…. |
| Stage IIA | 5-year survival: 25–35% | Surgery with potential neoadjuvant chemotherapy/RT. Neoadjuvant CROSS protocol… |
| Stage IIB | 5-year survival: 20–30% | Neoadjuvant chemotherapy/RT followed by esophagectomy. Consider induction… |
| Stage IIIA | 5-year survival: 15–25% | Neoadjuvant CROSS protocol (carboplatin + paclitaxel + 50.4 Gy RT) followed by… |
| Stage IIIC | 5-year survival: <10% | Palliative CRT or chemotherapy. Supportive care and symptom management… |
| Stage IVA | 5-year survival: <5% | Palliative chemotherapy (FOLFOX or platinum-fluorouracil). Endoscopic stent for… |
| Stage IVB | Median OS: 6–12 months with treatment | Palliative chemotherapy (FOLFOX, carboplatin-gemcitabine) or immunotherapy… |
Esophageal Cancer Treatment in Top Cities
Diagnosed with Stage IIIB Esophageal Cancer?
Our specialists can review your reports and create a personalised treatment plan.
Get a Free ConsultationAll Esophageal Cancer stages Esophageal Cancer overview
VICI Healthcare is for informational purposes only and does not replace professional medical advice. Always consult a qualified oncologist.